Tropical Diseases of Military Importance: A Centennial Perspective

By Peter Leggat In   Issue Volume 18 No. 4 Doi No https://doi-ds.org/doilink/11.2021-31321533/JMVH Vol 18 No 4

Abstract
Vector-borne diseases stand out as major concerns for military deployments. Of particular concern are malaria, arboviral diseases and, more recently, leishmaniasis. Vaccine preventable diseases also remain important globally. Other common problems, for example diarrhoeal disease and non-infectious hazards, such as trauma, also need to be addressed. Disclaimer: The author does not necessarily represent the views of the Australian Defence Force, The Australasian College of Tropical Medicine or of any other organisation mentioned in this paper.
Introduction
Despite a century of formal research in tropical medicine, tropical diseases remain a significant threat for many military deployments. Since the arrival of Dr Anton Breinl to head Australia’s first medical research institute on 1 January 1910, the Australian Institute of Tropical Medicine (see Figures 1 and 2), there have been many institutional milestones and advances in tropical medicine, some of which are recorded in Table 1. During this time, military forces from the region have frequently deployed to areas that have been characterised by extremes of environment, endemic disease, poverty, and inadequate public health resources. Tropical diseases have remained one of the greatest challenges to defence health services in the region. Historically, tropical diseases have been regarded as a significant factor influencing the outcome of major military campaigns, including the Second World War.1 It was one of Australia’s most highly regarded tropical medicine specialists and military physicians, Neil Hamilton Fair during the Second World War who  raised the importance of addressing tropical diseases such as malaria with the force commanders.2
Vector-borne tropical diseases
Vector-borne tropical diseases remain amongst the great problems for operational deployment of military personnel. Table 2 summarises potential tropical disease risks during deployment and some of the preventive measures. Some vector-borne diseases also represent a potential public health problem when returning home. Malaria remains the single most important vector-borne disease problem of the military worldwide.
Malaria
Malaria is a serious disease caused by a protozoan parasite largely confined to the tropics. Most life-threatening cases and deaths occur due to infection with Plasmodium falciparum malaria.4 However, infection due to P. vivax also remains important, especially as dormant liver stages can cause relapses, sometimes several, for months after returning home.4 Standard malaria countermeasures will be considered as part of planning for operational deployment based on current policy and disease patterns in the area of operations. Current countermeasures against malaria include the use of malarial chemoprophylaxis, personal protective measures, environmental health measures against disease vectors, early detection and treatment, and malaria eradication treatment.4 These measures are detailed in Australian Defence Force (ADF) Health Directives, e.g. HD215 on Malaria.
Arboviral diseases
There are many arboviral diseases, which have the potential to impact on military deployments. In Asia, dengue fever and Japanese encephalitis are major concerns for deployments; however in Africa Yellow fever is also a concern.
Yellow fever
Military personnel are one of the high-risk groups for yellow fever.5 The WHO requires yellow fever vaccination for those travelling to endemic regions, including west and central Africa as well as a number of areas in south and central America. Vaccination with the attenuated live viral vaccine (17D) confers protective immunity for about 10 years.4 Yellow fever vaccination should be appropriately documented and a booster should be considered after about 10 years. Military personnel should also be fully briefed on personal protective measures to avoid bites from infected mosquitoes.
Dengue
Dengue is a viral illness transmitted by various species of Aedes mosquitoes and is a major global public health problem.  Infection may range from subclinical disease to fever, arthralgia and rash, or be complicated by haemorrhagic diatheses or shock syndromes.  Treatment is supportive, while management of the problem is directed towards preventing transmission upon return home, which is a small potential risk in southern Africa. Numerous outbreaks of dengue can be attributed to travellers returning with the disease from Southeast Asia. Until a vaccination becomes available, the mainstays of dengue prevention are personal protective measures and environmental health measures against disease vectors.4 Further information can be found in Health Bulletins, e.g. HB No. 6/2000 Dengue. A useful update on Dengue can be found elsewhere.6
Japanese encephalitis
JE, transmitted by infective mosquitoes, is the leading cause of viral encephalitis in Asia. Up to a third of clinical cases die and about one half of clinical cases of JE have permanent residual neurological sequelae.7 The recent development and release of safer and more immunogenic second-generation JE vaccines have been a useful advance for military deployments in JE endemic areas. 7 Some of the background for the ADF’s involvement in JE vaccine research is given elsewhere.8
Filariasis
In Africa, soldiers may encounter several forms of filariasis, including lymphatic filariasis (LF), onchocerciasis and loiasis. In Asia, lymphatic filariasis is the predominant concern. LF is caused by three species of nematode parasites, which can be spread by a wide range of mosquito species.9 It has a widespread geographic distribution mainly in the tropical regions of the world. Wuchereria bancrofti is the most common and accounts for around 90% of cases.9 Brugia malayi is confined to east and southeast Asia and Brugia timori is found only in Timor and nearby islands.9 From World War II, there have been numerous outbreaks and reports of LF documented amongst troops deployed in southeast Asia and the western Pacific region.10 Countermeasures for filariasis include personal protective measures and eradication treatment.4 Further information for ADF personnel can be found in Health Bulletins, e.g. HB No. 4/2002 Lymphatic Filariasis.
Rickettsial diseases
A number of rickettsial diseases have a significant potential to impact on military deployments.11 Scrub typhus is widely endemic, particularly in a wide area of southeast Asia, Australia and the western Pacific region.11 In Africa, ticks are important vectors of a number of diseases, including rickettsial diseases, such as African tick bite fever. There are no vaccinations for rickettsial diseases and prevention hinges on the use of personal protective measures by military personnel.12 Weekly doses of 200 mg doxycycline can prevent scrub typhus, but the efficacy of daily doxycycline for malaria chemoprophylaxis as used against Orientia tsutsugamushi is unknown.12
Leishmaniasis
Leishmaniasis should be considered in those travelling to and returning from endemic areas. Leishmaniasis is caused by a protozoan parasite transmitted by the bite of infected female phlebotomine sandflies. There are several different forms, but the most common is cutaneous leishmaniasis (CL). CL is increasingly being reportedin travellers as they venture into endemic areas,13 in about 90 countries.14 Adventure travellers, humanitarian aid workers, military personnel and long term travellers may be at particular risk.14
Cutaneous Leishmaniasis
CL presents with skin sores, usually one or more chronic skin lesions where sandflies have fed. It has been coined the “Baghdad boil” reflecting the areas of operation where it is currently being encountered, including southwest and central Asia,15 although leishmaniasis is widely distributed in other locations around India, the Mediterranean basin, central Africa and South America. Skin lesions usually develop within a few weeks of being bitten and are unresponsive to antibiotics or steroids. Lesions commence as a papule then often enlarge and then ulcerate. They can be painless or painful, especially if secondarily infected. The peak sandfly period is April to November, peaking in September/October in the northern hemisphere.
Diagnosis of CL is normally through a biopsy or skin scraping.
Treatment is available, including sodium stibogluconate,14,16 but prevention is the best option. The following preventive measures may be useful and are mostly directed at reducing contact with sandflies: stay in air conditioned buildings where possible; spray out the accommodation area; permethrin impregnated clothing to cover as much of the body as possible; diethyl methyl- toluamide (or DEET) repellents; control of vermin and stray animals; and fine mesh bed net soaked in permethrin. Sandflies are most active from dusk to dawn.14
Other Forms
Other forms of leishmaniasis include the potentially disfiguring mucocutaneous or mucosal leishmaniasis and diffuse cutaneous leishmaniasis, primarily found in tropical South America, as well as visceral leishmaniasis (VL). Leishmaniases are regarded as a fairly heterogenous collection of clinical diseases caused by many different species of Leishmania, each with its own unique properties, including a fairly specific geographical location.15 VL is the most serious form of leishmaniasis and affects some of the body’s internal organs, most commonly the spleen, liver and bone marrow. It usually takes several months to years develop and may present with fever, weight loss, hepatomegaly and significant splenomegaly.14 VL is not common in travellers,14 but it has been reported amongst soldiers deployed to Iraq and Afghanistan.17 Severe cases of VL are typically fatal, if untreated.14 Health Bulletins provide further information for ADF personnel, e.g. HB No. 6/2003 Leishmaniasis.
Vaccine preventable diseases
Many infectious diseases of military personnel can be prevented by immunisation (see Table 2). There are few mandatory vaccines, for which certification is necessary. These include yellow fever and meningococcal meningitis.4  Meningococcal meningitis is of concern across the meningitis belt of sub-Saharan Africa, particularly in west Africa, and vaccination is warranted for deployment to these areas and other areas where the vaccine preventable strains of the disease are endemic.4,5 In addition to routine and national schedule vaccinations, there are a variety of vaccinations, which may be required for particular destinations. Influenza A and B are now considered major threats to military personnel in barracks as well as on deployment and influenza vaccination is starting to become more widely recommended.18
Zoonotic diseases
Zoonotic diseases may present a hazard for military deployments in rural Africa as well as many other parts of the world. Zoonotic diseases of concern include rabies, leptospirosis, bovine tuberculosis, anthrax, plague, and even certain viral haemorrhagic fevers.5 Rabies is amongst the most important of the zoonotic diseases. It is widely endemic in Africa and many other parts of the world and is an almost invariably fatal illness, spread by the bite of an infected animal. Military personnel are considered amongst the high-risk groups for rabies,5 and pre-exposure vaccination is indicated for troops deploying to rural Africa or other parts of the world where the disease is endemic and access to rabies immune globulin and post-exposure prophylaxis may be variable. Military personnel should be cautioned against approaching potentially infected animals and taught about first aid treatment of wounds caused by animal bites, including post-exposure prophylaxis. Leptospirosis is a widespread concern and is transmitted by infected domestic and wild animals, especially rodents. Military personnel coming into contact with urine-contaminated water may be infected. Rodent control measures need to be instituted in the field, as well as consideration of antibiotic chemoprophylaxis or eradication treatment. In Australia, doxycycline has been widely used to assist in prevention of leptospirosis and has been demonstrated to be both an effective chemoprophylactic and therapeutic agent.19 Further information for ADF personnel can be found in Health Directives, i.e. HD272. Leptospirosis.
Sexually transmitted diseases
Military personnel are often considered a risk group for sexually transmitted infections. In much of Africa and Asia, human immunodeficiency virus and hepatitis B and C virus are widespread.4 Pre-deployment, hepatitis B vaccination is important, as is hepatitis B and C and HIV serology, as baseline measures.5 Troops should be counselled on safe sex practices and preventing and managing percutaneous exposures to blood and bodily fluid.4
Schistosomiasis
Schistosomiasis remains one of the most important tropical diseases with a widespread distribution in more than 70 countries throughout parts of Africa, Asia and South America.Schistosomiasis is an important health risk for military deployments to rural Africa, where  it  causes chronic gastrointestinal schistosomiasis (Schistosoma mansoni) and genitourinary schistosomiasis (Schistosoma haematobium). Apart from avoidance of potentially infected water bodies or using protective clothing when fording streams, screening serology could be offered pre-deployment and post-deployment.5 Soldiers who seroconvert should be investigated and treated appropriately, usually with praziquantel. Alternatively, stool and urine examination for parasite eggs may be indicated for soldiers where infection is suspected,  but  where serology is not available or not useful due to previous exposure.5
Other infectious diseases
Other tropical diseases may affect military personnel on deployment. Prevention of diseases may require the use of personal protective measures by military personnel. Tuberculosis (TB) screening should also be considered for troops deploying from non-endemic regions to endemic regions. Active TB should be excluded in those exposed to TB or who are symptomatic.5 The importance of travellers’ diarrhoea should also not be underestimated in military deployments, 20 and is an important part of pre-deployment health briefing.  Skin infections can also common problems of deployments.5
Infectious disease risks posed by bioterrorism and emerging infections
The identification of the most likely and threatening of the potential biological weapons remains a joint effort of civilian and military public health and medical experts, informed also by law enforcement and intelligence.21 The development of public health and medical preparedness measures must then be instituted or developed against those threats that merit special concern. Some of the important criteria for this determination should include feasibility of aerosol dissemination, high case-fatality rates, potential for secondary spread, and the availability of protective vaccines or antimicrobial agents.21,22 Among some of the major causes of concern in recent years have been smallpox and anthrax, for which vaccines and/or prophylaxis are available; however a range of viral and bacterial agents have been identified and classified according to the threat that they pose.20, 22 There is also widespread stockpiling of antiviral treatment countermeasures to the Avian influenza and other potential pandemic influenza viruses, such as the recent pandemic (H1N1) 2009, particularly for use by health and military personnel, who may be called out to assist in disease control of any outbreak of the disease in human populations. There is however no substantial evidence for the effectiveness of these drugs in Avian influenza.23 Further information on Pandemic (H1N1) 2009 for ADF personnel can be found in Health Bulletins, e.g. HB No. 8/2009.
Non-infectious hazards of deployment
Sun exposure and heat illness remain a problem for soldiers, particularly on training exercises and military deployments. A US study by Carter et al showed that the diagnosis of the most serious form of heat illness, heat stroke, is actually increasing in terms of hospitalisation, although overall heat illness admissions reduced over the period 1980-2002.24 The complications of heat stroke, which can be life threatening -37 US soldiers died during 1980-2002 –  may include dehydration (17%), rhabdomyolysis (25%) and acute renal failure (13%).24  Injuries and accidents, especially fatal motor vehicle accidents and training injuries,25,26 represent a significant problem for military personnel on deployments. Other common problems include skin diseases, and field conditions during deployment, such as cold, sun exposure, heat, humidity and poor hygiene, can exacerbate skin disorders.27
Conclusion
Military deployments represent a significant risk of tropical diseases. In the past 100 years, there have been significant advances in countermeasures for many of these tropical diseases. In terms of infectious disease, vector-borne diseases, in particular malaria and the arboviruses, stand out as major concerns for military deployments. However, other common problems, for example diarrhoeal disease and non-infectious hazards, such as trauma, also need to be addressed.

Author Information

References

1.    Simmons JS. The Army’s new frontiers in tropical medicine. Annals Internal Med  1942; 17: 979-988. 2.    Ford E. Neil Hamilton Fairly (1891-1966). Med J Aust 1969; 2(20): 991-996. 3.    Anon. Human African trypanosomiasis (sleeping sickness): epidemiological update.  Wkly Epidemiol Rec. 2006; 81: 69-80. 4.    World Health Organization. International Travel and Health. Geneva: WHO; 2010. Available at: https://www.who.int/ith (accessed 23 August 20010) 5. Waner S, Durrheim DN, Leggat PA, Ross MH. Preventing infectious diseases in long-term travelers to rural Africa. J Travel Med. 2001; 8:304-308. 6.    Kitchener S. Dengue fever update.  J Mil Veterans Health 2010; 18(3): 42-43. 7.    Jelinek T. Ixiaro®: a new vaccine against Japanese encephalitis. Expert Rev Vaccines 2009; 8: 1501-1511. 8.    Kitchener S. The rise and fall of Japanese encephalitis vaccination in the ADF – Where to now? J Mil Vet Health 2010; 16(3): 14-20. 9.    Melrose WD. Lymphatic filariasis – new insights into an old disease. Int J Parasitol. 2002; 32:947-960. 10.    Melrose W, Leggat PA. Lymphatic filariasis: Disease outbreaks in military deployments from World War II. Mil Med. 2005; 170:585-589 11.    Kelly DJ, Richards AL, Temenak J, Strickman D, Dasch GA. The past and present threat of rickettsial diseases to military medicine and international public health. Clin Infect Dis. 2002; 15(Supp 4):S145-S169. 12.    Watt G, Parola P. Scrub typhus and tropical rickettsioses. Curr Opin Infect Dis. 2003; 16: 429-436. 13.    Magill AJ. Cutaneous Leishmaniasis in the returning traveler. Infect Dis Clin N Am 2005; 19: 241-266. 14.    Centers for Disease Control and Prevention. Prevention of Specific Diseases (Ch 4): Leishmaniasis. In. CDC Health Information for International Travel. URL: https://wwwn.cdc.gov/travel/yellowBookCh4-Leishmaniasis.aspx (accessed 23 August 2010) 15.    Anonymous. Update: Cutaneous leishmaniasis in U.S. military personnel-Southwest/Central Asia, 2002-2004. MMWR 2004; 53(12): 264-265. 16.    Minodier P, Parola P. Cutaneous leishmaniasis treatment. Travel Med Inf Dis 2007; 5: 150-158. 17.    Myles O, Wortmann GW, Cummings JF, Barthel RV, Patel S, Crum-Cianflone NF, Negin NS, Weina PJ, Ockenhouse CF, Joyce DJ, Magill AJ, Aronson NE, Gasser RA. Visceral leishmaniasis: clinical observations in 4 US army soldiers deployed to Afghanistan or Iraq, 2002-2004. Arch Intern Med 2007; 167: 1899-1901. 18.    Ikonen N, Pyhala R, Axelin T, Kleemola M, Korpela H. Reappearance of influenza B/Victoria/2/87-lineage viruses: epidemic activity, gentic diversity and vaccination efficacy in the Finnish Defence Forces. Epidemiol Infect 2005; 133: 263-271. 19.    Murray CK, Ellis MW, Hospenthal DR. Susceptibility of leptospira serovars to antimalarial agents. Am J Trop Med Hyg. 2004; 71:685-686. 20.    Sanders JW, Putnam SD, Riddle MS, Tribble DR. Military importance of diarrhea: lessons from the Middle East. Curr Opin Gastroenterol. 2005; 21:9-14. 21.    Venkatesh S, Memish ZA. Bioterrorism-a new challenge for public health. Int J Antimicrob Agents. 2003; 21:200-206. 22.    Robertson A. Bioterrorism - An Australian perspective. ADF Health. 2000; 1:99-106. 23.    Jefferson T, Demicheli V, Rivetti D, Di Pietrantonj C, Rivetti A. Antivirals for influenza in healthy adults: systemic review. Lancet. 2006; 367:303-313. 24.    Carter R, Cheuvront SN, Williams JO, Kolka MA, Stephenson LA, Sawka MN, Amoroso PJ. Epidemiology of hospitalizations and deaths from heat illness in soldiers. Med Sci Sports Exercise. 2005; 37:1338-1334. 25.    Hooper TI, Debakey SF, Bellis KS, Kang HK, Cowan DN, Lincoln AE, Gackstetter GD. Understanding the effect of deployment on the risk of fatal motor vehicle crashes: A nested case-control study of fatalities in Gulf War era veterans, 1991-1995. Accid Anal Prev. 2006; 38: 518-525. 26.    Gruhn J, Leggat PA, Müller R. Injuries presenting to Army physiotherapy in North Queensland, Australia. Mil Med. 1999; 164:145-152. 27.    Upjohn E, Kelly J. Skin diseases in war and peacekeeping. ADF Health. 2004; 5:64-68

Acknowledgements

Reader Feedback